Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Drug Pricing Authority Allows Increases In Six Bulk Drugs

This article was originally published in PharmAsia News

Executive Summary

India's National Pharmaceutical Pricing Authority has increased the cap on prices that can be charged for six bulk drugs. The increase covers cefataxime sodium, metronidazole, metronidazole benzoate, parachlorometaxylenol, ranitidine HCI and vitamen E acetate. Effective 15 days after official notification, drug makers are allowed to increase the prices of the drugs within a range of 3 percent to 12 percent. Makers of drugs using those ingredients are allowed to increase their own prices by about 8 percent if the price of the bulk drug rises by 12 percent. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts